4-methyl-4-{3-[(4-nitrobenzoyl)amino]propyl}morpholin-4-ium bromide(1603-27-6)
- Name: 4-methyl-4-{3-[(4-nitrobenzoyl)amino]propyl}morpholin-4-ium bromide
- Synonyms:Morpholinium, 4-methyl-4-[3-(p-nitrobenzamido)propyl]-, bromide(8CI);Morpholinium, 4-methyl-4-[3-[(4-nitrobenzoyl)amino]propyl]-, bromide(9CI);HC 5501;4-Methyl-4-[3-(p-nitrobenzamido)propyl]morpholiniumbromide (7CI);
- Molecular Formula:C15H22 N3 O4 . Br
- Molecular Weight:388.2569
- CAS Registry Number:1603-27-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1126-73-4/2-PROPENAMIDE, 3-(3-PYRIDINYL)-
- 94232-03-8/N,N'-ethylenebis[3-amino-4-methoxybenzenesulphonamide]
- 37853-43-3/Propanamide, 3-chloro-N-(3-(2-thienyl)-5-isoxazolyl)-
- 68311-24-0/Benzenesulfonic acid, dodecyl-, compd. with .alpha.,.alpha.'-[(octadecylimino)di-2,1-ethanediyl]bis[.omega.-hydroxypoly(oxy-1,2-ethanediyl)]
- 61050-22-4/N-(2,5-Dimethoxyphenyl)-4-[(4-ethoxyphenyl)azo]-3-hydroxy-2-naphthalenecarboxamide
- 94891-16-4/Ceramium rubrum, ext.
- 36284-95-4/1H-Indole-3-methanamine, N-methyl-
- 7066-06-0/N-(2-methoxy-5-methylphenyl)-5-[(4-methylpiperazin-1-yl)sulfonyl]pyridin-2-amine
- 91648-47-4/Sulfuric acid, mono(branched and linear C8-18 and C18-unsatd. alkyl) esters, sodium salts
- 81-46-9/1-AMINO-4-BENZAMIDOANTHRAQUINONE
- 134510-16-0/Phenylalanine, 2,2-((hydroxyphosphinylidene)bis(methylene))bis-, hydrate
- 133626-58-1/5H-Pyrido[2,3-b][1,5]benzodiazepin-5-one, 1,6-dihydro-6-(2-hydroxyethyl)-
- 21133-88-0/2-(p-Chlorophenyl)-4-ethyl-2,4-hexanediol
- 4934-32-1/(2S)-4-[2-[[(2R)-2-Carboxy-2,3-dihydro-5,6-dihydroxy-1H-indol]-1-yl]ethenyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid
- 7758-73-8/5 7-DIHYDROXY-4-PHENYLCOUMARIN
- 19293-86-8/G.L. 205
- 518051-66-6/strontium(+2) cation dinitrate
- 1603-27-6/4-methyl-4-{3-[(4-nitrobenzoyl)amino]propyl}morpholin-4-ium bromide
- 63869-94-3/3,3'-Methylenebis[5,6-dihydro-6-methyl-2H-pyran-2,4(3H)-dione]
- 21478-15-9/1,3-Benzenedisulfonic acid,4-[cyanobis[4-(diethylamino)phenyl]- methyl]-,disodium salt
- 129837-06-5/octyl [(3S,6S,9S,12S,15S,21S,24S,27R,33aS)-12,15-di[(2S)-butan-2-yl]-24-(4-methoxybenzyl)-2,8,11,14,20,27-hexamethyl-1,4,7,10,13,16,19,22,25,28-decaoxo-3,6,21-tri(propan-2-yl)dotriacontahydropyrido[1,2-d][1,4,7,10,13,16,19,22,25,28]oxanonaazacyclotriacont
- 146363-82-8/(2R,3R,4R)-6-cyclohexyl-3,4-dihydroxy-N-[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5-{[(2S)-3-(1H-imidazol-5-yl)-2-{[(naphthalen-1-yloxy)acetyl]amino}propanoyl]amino}-2-(1-methylethyl)hexanamide (non-preferred name)
- 38632-00-7/(6b)-6-Bromoandrost-4-ene-3,17-dione
- 132707-68-7/44-homooligomycin A
- 111472-70-9/1-(3-oxobutyl)azepanium chloride
- 82114-14-5/beta-endorphin, Trp(27)-2-nitrophenylsulfenyl chloride
- 32065-01-3/Phosphorodithioic acid,O-ethyl S-[2-(methylthio)propyl] S-propyl ester
- 21715-46-8/Etifoxine
- 67873-84-1/1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene, 2-ethyl-1-hexanol-blocked 1,3-Propanediol,2-ethyl-2-(hydroxymethyl)-,polymer with 1,3-diisocyanatomethylbenzene,2-ethyl-1-hexanol-blocked
- 469-26-1/ISOPETASIN